Prostate Cancer - Results from #1860

Genetic and biological drivers of prostate cancer disparities in Black men. November 16, 2023

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness. November 16, 2023

Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas. November 15, 2023

Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia. November 15, 2023

Robot-Assisted Radical Prostatectomy in Renal Transplant Recipients: A Systematic Review. November 15, 2023

MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease. November 15, 2023

Association between prediagnostic PSA and prostate cancer probability in Black and non-Hispanic White men. November 15, 2023

Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. November 14, 2023

National long-term survival estimates after radical prostatectomy for prostate cancer. November 14, 2023

Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study. November 14, 2023

Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression. November 14, 2023

Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. November 14, 2023

Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors. November 14, 2023

Social Media Interventions for Patients and Public: Opportunities and Challenges for the Urology Community November 13, 2023

Determining clinical perspectives and strategies for improving enrollment of minoritized communities in prostate cancer clinical trials. November 13, 2023

The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer. November 13, 2023

Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer. November 13, 2023

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN. November 13, 2023

Radiation therapy margin reduction for patients with localized prostate cancer: A prospective study of the dosimetric impact and quality of life. November 13, 2023

A contemporary review of the treatments and challenges associated with penile rehabilitation after radical prostatectomy including a proposed optimal approach. November 10, 2023

Page 94 of 1439